Speaking at the Amgen One conference in Melbourne, Senior Postdoctoral Researcher at the South Australian Health and Medical Research Institute (SAHMRI) Dr Duncan Hewett discussed his team’s work on subclonal heterogeneity and progression in multiple myeloma, noting that single nucleotide variant (SNV) load may not be as important as first thought. Clonal plasma cells have ...
SNVs – the more the nastier?
13 Mar 2019
Sponsored by Amgen Australia Pty Ltd